103587-51-5

Basic information

• Product Name: O-(tert-butyldiphenylsilyl)hydroxylamine
• Synonyms: O-(tert-butyldiphenylsilyl)hydroxylamine;HydroxylaMine, O-[(1,1-diMethylethyl)diphenylsilyl]-;O-(t-Butyldiphenylsilyl)hydroxylamine;O-(tert-Butyldiphenylsilyl)
• CAS NO: 103587-51-5
• Molecular Formula: C₁₆H₂₁NOSi
• Molecular Weight: 271
• Mol File: 103587-51-5.mol

Chemical Properties

• Melting Point: 90 °C
• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• Solubility: Chloroform, Ethyl Acetate (Slightly)
• CAS DataBase Reference: O-(tert-butyldiphenylsilyl)hydroxylamine(CAS DataBase Reference)
• NIST Chemistry Reference: O-(tert-butyldiphenylsilyl)hydroxylamine(103587-51-5)
• EPA Substance Registry System: O-(tert-butyldiphenylsilyl)hydroxylamine(103587-51-5)

Safety Data

• Hazardous Substances Data: 103587-51-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
O-(tert-butyldiphenylsilyl)hydroxylamine is used as an intermediate in the synthesis of N-Hydroxy Vortioxetine O-β-D-Glucuronide Sodium Salt (H996005). O-(tert-butyldiphenylsilyl)hydroxylamine is a metabolite of Vortioxetine (V766000, HBr), a multimodal serotonergic agent with a wide range of applications in the treatment of various conditions related to the serotonin system.
In the pharmaceutical industry, O-(tert-butyldiphenylsilyl)hydroxylamine plays a vital role in the development of Vortioxetine and its derivatives. Vortioxetine is known for its ability to inhibit multiple serotonin receptors, including 5-HT1A, 5-HT1B, 5-HT3A, and 5-HT7, as well as the serotonin transporter (SERT). This unique profile makes Vortioxetine a promising candidate for the treatment of various psychiatric and neurological disorders, such as depression, anxiety, and obsessive-compulsive disorder.
The use of O-(tert-butyldiphenylsilyl)hydroxylamine in the synthesis of Vortioxetine and its metabolites highlights its importance in the development of novel therapeutic agents with potential applications in the treatment of a wide range of conditions. Its unique structural features and reactivity make it a valuable component in the design and synthesis of new drugs targeting the serotonin system.

Upstream product

• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 118684-94-9 O-(tert-butyldiphenylsilyl)-N-<1-methyl-1-<4-(benzyloxy)phenyl>ethyl>hydroxylamine 
• 126754-33-4 (E)-trans-2-chloro-3-ethylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-33-4 (Z)-cis-2-chloro-3-ethylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-33-4 (E)-cis-2-chloro-3-ethylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-32-3 (Z)-cis-2-chloro-3-methylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-32-3 (E)-cis-2-chloro-3-methylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-32-3 (E)-trans-2-chloro-3-methylcyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-34-5 (E)-cis-2-chloro-3-(1-methylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-34-5 (E)-trans-2-chloro-3-(1-methylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-35-6 (E)-trans-2-chloro-3-(1,1-dimethylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-35-6 (Z)-cis-2-chloro-3-(1,1-dimethylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-35-6 (E)-cis-2-chloro-3-(1,1-dimethylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-36-7 (E)-trans-2-chloro-5-(1,1-dimethylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 
• 126754-36-7 (Z)-cis-2-chloro-5-(1,1-dimethylethyl)cyclohexanone O-(tert-butyldiphenylsilyl)oxime 

Relevant articles and documents

Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate: Towards new carbonic anhydrase glycoinhibitors

Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate allowed the preparation of hydroxysulfamide glycosides in good yields with a good α stereoselectivity. A variety of mono-saccharide derivatives was synthesized using this

Synthesis of 3,5-Disubstituted Isoxazoles through a 1,3-Dipolar Cycloaddition Reaction between Alkynes and Nitrile Oxides Generated from O-Silylated Hydroxamic Acids

In this paper, we report the regioselective synthesis of 3,5-disubstituted isoxazoles by 1,3-dipolar cycloaddition between alkynyl dipolarophiles and nitrile oxide dipoles generated in-situ from O-silylated hydroxamic acids in the presence of trifluoromethanesulfonic anhydride and NEt3. Thanks to the mild, metal-free and oxidant-free conditions that this strategy offers, the reaction was successfully applied to a wide variety of alkynyl dipolarophiles, demonstrating the tolerance of this approach to diverse functional groups. In particular, we have shown that the method was compatible with biological molecules such as peptides and peptide nucleic acids (PNA). This protocol constitutes another example of metal-free 1,3-dipolar cycloaddition leading to the regioselective formation of isoxazoles.

Thiyl radical-mediated cyclization of ω-alkynyl O-tert-butyldiphenylsilyloximes

ω-Alkynyl O-tert-butyldiphenylsilyloximes, upon treatment with odorless 4-tert-butylbenzenethiol in the presence of azobisisobutyronitrile (AIBN) in refluxing benzene, underwent addition of a thiyl radical to the alkynyl group followed by radical cyclizat

ANTICANCER COMPOUNDS

This invention features compounds having formula (I): wherein, R1, R 2,R3, R4, R6, R7, T, X, and Y are as defined herein. This invention also features a method for treating cancer. The method includes administrating to a subject in need thereof a compound of formula (I).

METABOLITES OF PRINOMASTAT AND THEIR SYTHESIS

Metabolites of a matrix metalloproteinase inhibitor prinomastat their synthesis composition, and method of using same. These metabolites are: (3S)-N-hydroxy-4-(4-((1-oxy-pyrid-4-yl)oxy)benzenesulfonyl)-2,2-dimethyl-tetrahydro-2H-1,4-thiazine-3-carboxamide

The vinylogous anomeric effect in 3-alkyl-2-chlorocyclohexanone oximes and oxime ethers

A series of trans-3-alkyl-2-chlorocyclohexanones, 2(methyl, ethyl, isopropyl, and tert-butyl), have been prepared and shown to exist predominantly in the diequatorial chair conformation except the tert-butyl derivative which prefers a twist-boat. Formatio